Impact BioMedical, INC. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-03-11: Form 10-K; Exhibit 10.22; Description Impact BioMedical Inc. 2023 Employee, Director, and Consultant Equity Incentive Compensation Plan.
- 2026-03-04: Form 8-K; Exhibit 10.3; Description Amendment No. 1 to the Transition Arrangement Agreement, dated February 27, 2026.
- 2026-03-04: Form 8-K; Exhibit 10.2; Description Amendment No. 1 to the Impact Stockholder Voting and Support Agreement, dated February 27, 2026.
- 2026-03-04: Form 8-K; Exhibit 10.1; Description Amendment No. 1 to the Merger and Share Exchange Agreement, dated February 27, 2026.
| Filed | Form | Exhibit | Description |
|---|
| 2026-03-11 | 10-K | 10.22 | Impact BioMedical Inc. 2023 Employee, Director, and Consultant Equity Incentive Compensation Plan |
|---|
| 2026-03-04 | 8-K | 10.3 | Amendment No. 1 to the Transition Arrangement Agreement, dated February 27, 2026 |
|---|
| 2026-03-04 | 8-K | 10.2 | Amendment No. 1 to the Impact Stockholder Voting and Support Agreement, dated February 27, 2026 |
|---|
| 2026-03-04 | 8-K | 10.1 | Amendment No. 1 to the Merger and Share Exchange Agreement, dated February 27, 2026 |
|---|
| 2025-07-28 | 8-K | 10.1 | Agreement to Convert Debt to Equity and other Considerations, dated July 21, 2025 |
|---|
| 2025-06-23 | 8-K | 10.2 | Form of Transition Arrangement Agreement by and among Dr Ashleys Limited, Impact BioMedical Inc., Frank D. Heuszel and DSS, Inc. |
|---|
| 2025-06-23 | 8-K | 10.1 | Form of Voting and Support Agreement by and among Dr Ashleys Limited, Dr Ashleys Nevada Sub, Inc., Impact BioMedical Inc., Dr Ashleys Bio Labs Limited, Kanans Visvanats and certain stockholders of Impact BioMedical Inc. |
|---|
| 2025-03-28 | 8-K | 10.1 | Partial Settlement of Debt Agreement, dated March 24, 2025 |
|---|
| 2024-10-08 | 8-K | 10.1 | Executive Employment Agreement, dated as of October 3, 2024, between Impact Biomedical Inc. and Frank D. Heuszel. |
|---|
| 2024-01-22 | 8-K | 10.1 | Amendment to Promissory Note effective January 18, 2024 between Impact BioMedical Inc. and DSS, Inc. |
|---|
| 2023-11-06 | 8-K | 10.1 | Share Exchange Agreement between Impact BioMedical Inc. and DSS BioHealth Security, Inc., dated October 31, 2023 |
|---|